Coordinated Hospital-Home Fecal Microbiota Transplantation via Percutaneous Endoscopic Cecostomy for Recurrent Steroid-Dependent Ulcerative Colitis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Since its introduction as an alternative intestinal microbiota alteration approach, fecal microbiota transplantation (FMT) has been increasingly used as a treatment of choice for patients with ulcerative colitis (UC), but no reports exist regarding FMT via percutaneous endoscopic cecostomy (PEC). This report describes the case of a 24-year-old man with a 7-year history of recurrent, steroid-dependent UC. He received FMT via PEC once per day for 1 month in the hospital. After the remission of gastrointestinal symptoms, he was discharged from the hospital and continued FMT via PEC twice per week for 3 months at home. The frequency of stools decreased, and the characteristics of stools improved soon thereafter. Enteral nutrition was regained after 1 week, and an oral diet was begun 1 month later. Two months after the FMT end point, the patient resumed a normal diet, with formed soft stools once per day. The follow-up colonoscopy showed normal mucus membranes; then, the PEC set was removed. On the subsequent 12 months follow-up, the patient resumed orthobiosis without any gastrointestinal discomfort and returned to work. This case emphasizes that FMT via PEC can not only induce remission but also shorten the duration of hospitalization and reduce the medical costs; therefore, this approach should be considered an alternative option for patients with UC.
Abstract
Since its introduction as an alternative intestinal microbiota alteration approach, fecal microbiota transplantation (FMT) has been increasingly used as a treatment of choice for patients with ulcerative colitis (UC), but no reports exist regarding FMT via percutaneous endoscopic cecostomy (PEC). This report describes the case of a 24-year-old man with a 7-year history of recurrent, steroid-dependent UC. He received FMT via PEC once per day for 1 month in the hospital. After the remission of gastrointestinal symptoms, he was discharged from the hospital and continued FMT via PEC twice per week for 3 months at home. The frequency of stools decreased, and the characteristics of stools improved soon thereafter. Enteral nutrition was regained after 1 week, and an oral diet was begun 1 month later. Two months after the FMT end point, the patient resumed a normal diet, with formed soft stools once per day. The follow-up colonoscopy showed normal mucus membranes; then, the PEC set was removed. On the subsequent 12 months follow-up, the patient resumed orthobiosis without any gastrointestinal discomfort and returned to work. This case emphasizes that FMT via PEC can not only induce remission but also shorten the duration of hospitalization and reduce the medical costs; therefore, this approach should be considered an alternative option for patients with UC.
참고문헌 (26)
- Kane SV, "Systematic review: adherence issues in the treatment of ulcerative colitis", Aliment Pharmacol Ther, 23, pp.577~585 (2006)
- Tinsley A, "Early readmission in patients hospitalized for ulcerative colitis:incidence and risk factors", Scand J Gastroenterol, 50, pp.1103~1109 (2015)
- Anderson JL, "Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease", Aliment Pharmacol Ther, 36, pp.503~516 (2012)
- Talley NJ, "An evidence-based systematic review on medical therapies for inflammatory bowel disease", Am J Gastroenterol, 106(1), pp.S2~S25 (2011)
- 박성철, "Current and Emerging Biologics for Ulcerative Colitis", Gut and Liver, 9(1), pp.18~27 (2015), 거트앤리버 발행위원회
- Ford AC, "Ulcerative colitis", BMJ, 346, pp.f432~ (2013)
- Moayyedi P, "Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial", Gastroenterology, 149(e6), pp.102~109 (2015)
- Kellermayer R, "Serial fecal microbiota transplantation alters mucosal gene expression in pediatric ulcerative colitis", Am J Gastroenterol, 110, pp.604~606 (2015)
- Grinspan AM, "Fecal microbiota transplantation for ulcerative colitis: not just yet", Gastroenterology, 149, pp.15~18 (2015)
- Satsangi J, "The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications", Gut, 55, pp.749~753 (2006)
- D’Haens G, "A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis", Gastroenterology, 132, pp.763~786 (2007)
- Kornbluth A, "Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee", Am J Gastroenterol, 99, pp.1371~1385 (2004)
- Ponsky JL, "Percutaneous endoscopic cecostomy:a new approach to nonobstructive colonic dilation", Gastrointest Endosc, 32, pp.108~111 (1986)
- Conrad K, "Diagnosis and classification of ulcerative colitis", Autoimmun Rev, 13, pp.463~466 (2014)
- 은창수, "Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?", Gut and Liver, 9(5), pp.567~568 (2015), 거트앤리버 발행위원회
- Brandt LJ, "An overview of fecal microbiota transplantation:techniques, indications, and outcomes", Gastrointest Endosc, 78, pp.240~249 (2013)
- Eiseman B, "Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis", Surgery, 44, pp.854~859 (1958)
- Schwan A, "Relapsing clostridium difficile enterocolitis cured by rectal infusion of homologous faeces", Lancet, 2, pp.845~ (1983)
- Borody TJ, "Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?", Med J Aust, 150, pp.604~ (1989)
- Sha S, "Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children", Aliment Pharmacol Ther, 39, pp.1003~1032 (2014)
- Rossen NG, "Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis", Gastroenterology, 149(e4), pp.110~118 (2015)
- Aas J, "Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube", Clin Infect Dis, 36, pp.580~585 (2003)
- Persky SE, "Treatment of recurrent Clostridium difficileassociated diarrhea by administration of donated stool directly through a colonoscope", Am J Gastroenterol, 95, pp.3283~3285 (2000)
- Silverman MS, "Success of self-administered home fecal ransplantation for chronic Clostridium difficile infection", Clin Gastroenterol epatol, 8, pp.471~473 (2010)
- Guo B, "Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease", Aliment Pharmacol Ther, 35, pp.865~875 (2012)
- Lynch CR, "Percutaneous endoscopic cecostomy in adults: a case series", Gastrointest Endosc, 64, pp.279~282 (2006)